Robert A. Stern, PhD
Professor
Boston University School of Medicine
Dept of Neurology

PhD, University of Rhode Island
MA, University of Rhode Island



As the Clinical Core Director of the NIA-funded Boston University Alzheimer’s Disease Center (BU ADC), I oversee a multidisciplinary group of talented scientists and clinicians and direct the center’s longitudinal research registry, as well as several NIH- and industry-funded diagnostic, prevention, and treatment trials. The major focus of my current research is on the long-term effects of repetitive head impacts in athletes, including the neuropathological, risk factors (genetic and head impact exposure), neuroimaging, biomarker development, and clinical diagnosis and descriptions of the neurodegenerative disease, chronic traumatic encephalopathy (CTE). Other areas of my current and recent research program include the diagnosis, risk factors, and treatment of cognitive decline and neuropsychiatric dysfunction in aging. I have also published extensively on the psychometric properties of many widely used tests in neuropsychology, as well as the use of various instruments and biomarkers in the differential diagnosis of neurodegenerative disease. In addition, I have developed several commonly used tests and instruments, including the Neuropsychological Assessment Battery (NAB). I have had leadership positions in several training programs, have mentored over 40 trainees, and play a key role in the professional development of junior faculty in the BU School of Medicine (BUSM) Neurology Department.

Professor
Boston University School of Medicine
Anatomy & Neurobiology


Professor
Boston University School of Medicine
Neurosurgery


Director of Clinical Research
Boston University School of Medicine
Chronic Traumatic Encephalopathy Center


Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Division of Graduate Medical Sciences


Active Staff Privileges
Boston Medical Center
Neurology




Protocol # 54861911ALZ2003, A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigation the Efficacy and Safety of JNJ-54861911 in Subjects who are Asymp
10/27/2017 - 02/24/2023 (PI)
Janssen Research & Development, LLC

Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors
12/15/2015 - 11/30/2022 (PI)
NIH/National Institute of Neurological Disorders & Stroke
5U01NS093334-02

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials ("RAmP" or 18F-AV-45-A25)
03/20/2017 - 03/19/2020 (PI)
Avid Radiopharmaceuticals, Inc.


Tau PET Imaging for the USC Alzheimer's Therapeutic Research Institute (USC ATRI) A4 Trial (â??A4 TAUâ?)
10/01/2016 - 12/31/2018 (PI)
University of Southern California Fundation for NIH


Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
12/11/2015 - 12/10/2018 (PI)
University of Southern California Eli Lilly and Co


Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
11/01/2015 - 10/31/2018 (PI)
University of Southern California Alzheimer's Assoc


A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia (The DAYBREAK Study)
10/24/2016 - 10/23/2018 (PI)
Eli Lilly and Company


An Open label, multicenter study evaluating the imaging characteristics of a follow up F-AV-1451 scan in subjects that participated in the confirmatory cohort of FV-AV-1451-A05
09/29/2016 - 09/28/2018 (PI)
Avid Radiopharmaceuticals, Inc.


Measuring Glial metabolism in repetitive brain trauma and Alzheimer's Disease
08/15/2015 - 08/14/2018 (PI)
The Brigham and Women's Hospital, Inc. DOD Army Med Resrch


A placebo-controlled, double-blind, parallel-group, bayesian adaptive randomization design and dose regimen-finding study to evaluate the safety tolerability and efficacy of BAN2401 in subjects with
02/01/2013 - 06/30/2018 (PI)
Eisai, Inc


Showing 10 of 39 results. Show All Results



Yr Title Project-Sub Proj Pubs
2018 Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors 5U01NS093334-03 1
2017 Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors 5U01NS093334-02 1
2017 Core B: Clinical Core 2P30AG013846-21-6895 428
2016 Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors 1U01NS093334-01 1
2013 Chronic Traumatic Encephalopathy: Clinical Presentation and Biomarkers 5R01NS078337-03 19
2013 OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE 5R01CA129769-05 28
2012 Chronic Traumatic Encephalopathy: Clinical Presentation and Biomarkers 5R01NS078337-02 19
2012 OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE 5R01CA129769-04 28
2012 Subclinical Hypothyroidism: Mood, Cognition and the effect of L-thyroxine treatme 5R01MH080295-05 24
2011 Chronic Traumatic Encephalopathy: Clinical Presentation and Biomarkers 1R01NS078337-01A1 19
Showing 10 of 23 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Lepage C, Muehlmann M, Tripodis Y, Hufschmidt J, Stamm J, Green K, Wrobel P, Schultz V, Weir I, Alosco ML, Baugh CM, Fritts NG, Martin BM, Chaisson C, Coleman MJ, Lin AP, Pasternak O, Makris N, Stern RA, Shenton ME, Koerte IK. Limbic system structure volumes and associated neurocognitive functioning in former NFL players. Brain Imaging Behav. 2018 May 19.View Related Profiles. PMID: 29779184; DOI: 10.1007/s11682-018-9895-z;.
     
  2. Alosco ML, Mez J, Tripodis Y, Kiernan PT, Abdolmohammadi B, Murphy L, Kowall NW, Stein TD, Huber BR, Goldstein LE, Cantu RC, Katz DI, Chaisson CE, Martin B, Solomon TM, McClean MD, Daneshvar DH, Nowinski CJ, Stern RA, McKee AC. Age of First Exposure to Tackle Football and Chronic Traumatic Encephalopathy. Ann Neurol. 2018 Apr 30.View Related Profiles. PMID: 29710395.
     
  3. Guenette JP, Stern RA, Tripodis Y, Chua AS, Schultz V, Sydnor VJ, Somes N, Karmacharya S, Lepage C, Wrobel P, Alosco ML, Martin BM, Chaisson CE, Coleman MJ, Lin AP, Pasternak O, Makris N, Shenton ME, Koerte IK. Automated versus manual segmentation of brain region volumes in former football players. Neuroimage Clin. 2018; 18:888-896.View Related Profiles. PMID: 29876273.
     
  4. Clapp JD, Luta G, Small BJ, Ahles TA, Root JC, Graham D, Hurria A, Jacobsen PB, Jim H, McDonald BC, Stern RA, Saykin AJ, Mandelblatt JS. The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates. Arch Clin Neuropsychol. 2018 Feb 17. PMID: 29471454.
     
  5. Tao Q, Zhu H, Chen X, Stern RA, Kowall N, Au R, Blusztajn JK, Qiu WQ. Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease. J Alzheimers Dis. 2018; 62(2):597-609.View Related Profiles. PMID: 29480193.
     
  6. Sugarman MA, Alosco ML, Tripodis Y, Steinberg EG, Stern RA. Neuropsychiatric Symptoms and the Diagnostic Stability of Mild Cognitive Impairment. J Alzheimers Dis. 2018; 62(4):1841-1855.View Related Profiles. PMID: 29614641; DOI: 10.3233/JAD-170527;.
     
  7. Alosco ML, Sugarman MA, Besser LM, Tripodis Y, Martin B, Palmisano JN, Kowall NW, Au R, Mez J, DeCarli C, Stein TD, McKee AC, Killiany RJ, Stern RA. A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis. 2018; 63(4):1347-1360.View Related Profiles. PMID: 29843242; DOI: 10.3233/JAD-180017;.
     
  8. Alosco ML, Jarnagin J, Rowland B, Liao H, Stern RA, Lin A. Magnetic Resonance Spectroscopy as a Biomarker for Chronic Traumatic Encephalopathy. Semin Neurol. 2017 Oct; 37(5):503-509. PMID: 29207411.
     
  9. Schultz V, Stern RA, Tripodis Y, Stamm J, Wrobel P, Lepage C, Weir I, Guenette JP, Chua A, Alosco ML, Baugh CM, Fritts NG, Martin BM, Chaisson CE, Coleman MJ, Lin AP, Pasternak O, Shenton ME, Koerte IK. Age at First Exposure to Repetitive Head Impacts Is Associated with Smaller Thalamic Volumes in Former Professional American Football Players. J Neurotrauma. 2018 Jan 15; 35(2):278-285.View Related Profiles. PMID: 28990457; DOI: 10.1089/neu.2017.5145;.
     
  10. Ashendorf L, Alosco ML, Bing-Canar H, Chapman KR, Martin B, Chaisson CE, Dixon D, Steinberg EG, Tripodis Y, Kowall NW, Stern RA. Clinical Utility of Select Neuropsychological Assessment Battery Tests in Predicting Functional Abilities in Dementia. Arch Clin Neuropsychol. 2017 Nov 08; 1-11.View Related Profiles. PMID: 29126099; DOI: 10.1093/arclin/acx100;.
     
Showing 10 of 161 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 161 publications over 32 distinct years, with a maximum of 14 publications in 2015 and 2016

YearPublications
19861
19871
19891
19901
19914
19926
19936
19943
19955
19966
19974
19981
19993
20005
20011
20022
20036
20042
20051
20062
20074
20085
20094
20105
20117
201210
20136
201412
201514
201614
201712
20187
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Alzheimer's Disease
Chronic Traumatic Encephalopathy
Concussion
Dementia
Neuropsychology
Contact for Mentoring:


72 E. Concord St Robinson (B)
Boston MA 02118
Google Map


Stern's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department